Can Nirma make the jump from suds to pills?
Finshots Daily
00:00
Strategic Shift in Pharma Industry: The Rise of API Business
Exploring the strategy of Indian pharma companies, like Glennmark life sciences, in becoming contract manufacturers for APIs to reduce dependence on China and boost their own API business.
Play episode from 04:00
Transcript
